aTyr Pharma | LIFE - Ebitda

Stock Price
0.88
Daily Change
0.03 3.41%
Monthly
-10.58%
Yearly
-78.08%
Q1 Forecast
0.82

aTyr Pharma reported $-26.58M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Ardelyx USD 5.57M 17.44M Sep/2025
aTyr Pharma USD -26.58M 26.32M Sep/2025
Biogen USD 573.2M 253.7M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Cipla INR 12.55B 6.4B Dec/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 3.13B 1.17B Dec/2025
Curis USD -12.3M 231K Sep/2023
Galapagos EUR 2.42M 161.13M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Grifols EUR 482.04M 7.04M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
United Therapeutics USD 379.5M 83.4M Dec/2025
Xoma USD 2.52M 7.98M Jun/2024